20.01.2026 – 4 min

Polyagonist Therapies in Obesity: A systems-level case study enabled by continuous in vivo phenotyping

Introduction  Obesity and type 2 diabetes are not single-pathway diseases. They emerge from a complex disruption of whole-body energy homeostasis involving the gut, brain, pancreas,...